Showing 1 - 17 results of 17 for search 'Ruiwen ZHANG', query time: 0.05s
Refine Results
-
1
-
2
Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen by Jiang-Jiang Qin, Jiang-Jiang Qin, Xin Li, Xin Li, Wei Wang, Wei Wang, Wei Wang, Xiaolin Zi, Xiaolin Zi, Ruiwen Zhang, Ruiwen Zhang, Ruiwen Zhang
Published 2017-12-01
Article -
3
Two Birds with One Stone: NFAT1-MDM2 Dual Inhibitors for Cancer Therapy by Wei Wang, Atif Zafar, Mehrdad Rajaei, Ruiwen Zhang
Published 2020-05-01
Article -
4
-
5
-
6
-
7
-
8
-
9
JKA97, a novel benzylidene analog of harmine, exerts anti-cancer effects by inducing G1 arrest, apoptosis, and p53-independent up-regulation of p21. by Xinyi Yang, Wei Wang, Jiang-Jiang Qin, Ming-Hai Wang, Horrick Sharma, John K Buolamwini, Hui Wang, Ruiwen Zhang
Published 2012-01-01
Article -
10
-
11
Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action by Surendra R. Punganuru, Viswanath Arutla, Wei Zhao, Mehrdad Rajaei, Hemantkumar Deokar, Ruiwen Zhang, John K. Buolamwini, Kalkunte S. Srivenugopal, Wei Wang
Published 2020-07-01
Article -
12
Corrigendum to “A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance” [Genes Dis 694 (2019) 419–430] by Wei Wang, Bo Hu, Jiang-Jiang Qin, Jianwen Cheng, Xin Li, Mehrdad Rajaei, Jia Fan, Xin-Rong Yang, Ruiwen Zhang
Published 2020-03-01
Article -
13
-
14
Preclinical Evaluation of Anticancer Efficacy and Pharmacological Properties of FBA-TPQ, a Novel Synthetic Makaluvamine Analog by Sadanandan E. Velu, Ming-Hai Wang, Ruiwen Zhang, Wei Wang, Dwayaja H. Nadkarni, Sukesh Voruganti, Srinivasan Murugesan, Xu Zhang, Xiangrong Zhang, Hongxia Xu
Published 2012-05-01
Article -
15
Targeting MDM2 for Neuroblastoma Therapy: In Vitro and In Vivo Anticancer Activity and Mechanism of Action by Wei Wang, Xinjie Wang, Mehrdad Rajaei, Ji Youn Youn, Atif Zafar, Hemantkumar Deokar, John K. Buolamwini, Jianhua Yang, Jennifer H. Foster, Jia Zhou, Ruiwen Zhang
Published 2020-12-01
Article -
16
Preclinical Pharmacology of BA-TPQ, a Novel Synthetic Iminoquinone Anticancer Agent by Ruiwen Zhang, Wei Wang, Sadanandan E. Velu, Xinyi Yang, Charnell I. Sommers, Elizabeth R. Rayburn, Xu Zhang, Evrim Gurpinar, Hongxia Xu, Xiangrong Zhang, Scharri J. Ezell, Haibo Li
Published 2010-07-01
Article -
17
KCN1, a novel synthetic sulfonamide anticancer agent: in vitro and in vivo anti-pancreatic cancer activities and preclinical pharmacology. by Wei Wang, Lin Ao, Elizabeth R Rayburn, Hongxia Xu, Xiangrong Zhang, Xu Zhang, Subhasree Ashok Nag, Xuming Wu, Ming-Hai Wang, Hui Wang, Erwin G Van Meir, Ruiwen Zhang
Published 2012-01-01
Article